Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Data Acquisition and Transmission Solutions

Belden launches 4-Channel SMPTE cable and VFD cable glands designed to provide enhanced security, better performance, and seamless integration.

Belden2

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Belden’s data acquisition and transmission products include:

Belden 4-Channel SMPTE Cable is a multi-channel hybrid cable that allows four cameras to be connected to a single installed cable. The 4-Channel SMPTE is available in riser and plenum versions, features a black outer jacket and is backed by Belden's industry-leading standard 10-year warranty.

Belden VFD Cable Glands allow explosion-proof or general-purpose ingress of VFD cables into enclosures and devices. Featuring a pass-through design for shield/ground isolation, VFD Cable Glands are ideal for all types of unarmored tray cables, flexible cables and cords—even in the most demanding industrial environments.


Fill out the form below to request more information about Data Acquisition and Transmission Solutions
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?